Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry G Bone

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2007
Nonmalignant complications of Paget's diseaseHenry G Bone
Current Osteoporosis Reports|July 23, 2005
Intravenous bisphosphonate therapy for osteoporosis: where do we stand?Henry G Bone, Werner Schurr
Treatments in Endocrinology|October 30, 2004
Combining bisphosphonates with hormone therapy for postmenopausal osteoporosisMargaret E Fadanelli, Henry G Bone
Bonekey Reports|June 13, 2015
Effects of estrogen depletion and drug treatment on collagen microstructure: implicationsJoseph M Wallace, Henry G Bone
The Lancet. Diabetes & Endocrinology|September 24, 2017
Denosumab treatment in postmenopausal women with osteoporosis - Authors' replyHenry G Bone, Rachel B Wagman, Nicola Pannacciulli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 20, 2005
Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?Henry G Bone, Arthur C Santora, Arghya Chattopadhyay, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 31, 2012
A single-dose study of denosumab in patients with various degrees of renal impairmentGeoffrey A Block, Henry G Bone, Liang Fang, et al.
Therapeutic Advances in Endocrinology and Metabolism|August 25, 2015
Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementationJoseph R Tucci, Henry G Bone, Guoqin Su, et al.
Clinical Therapeutics|May 24, 2008
Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluationE Michael Lewiecki, Ann M Babbitt, Veronica K Piziak, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Alendronate increases bone mass and reduces bone markers in postmenopausal African-American womenNorman H Bell, John P Bilezikian, Henry G Bone, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 19, 2007
Nonmalignant complications of Paget's diseaseHenry G Bone
Current Osteoporosis Reports|July 23, 2005
Intravenous bisphosphonate therapy for osteoporosis: where do we stand?Henry G Bone, Werner Schurr
Treatments in Endocrinology|October 30, 2004
Combining bisphosphonates with hormone therapy for postmenopausal osteoporosisMargaret E Fadanelli, Henry G Bone
Bonekey Reports|June 13, 2015
Effects of estrogen depletion and drug treatment on collagen microstructure: implicationsJoseph M Wallace, Henry G Bone
The Lancet. Diabetes & Endocrinology|September 24, 2017
Denosumab treatment in postmenopausal women with osteoporosis - Authors' replyHenry G Bone, Rachel B Wagman, Nicola Pannacciulli, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 20, 2005
Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?Henry G Bone, Arthur C Santora, Arghya Chattopadhyay, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 31, 2012
A single-dose study of denosumab in patients with various degrees of renal impairmentGeoffrey A Block, Henry G Bone, Liang Fang, et al.
Therapeutic Advances in Endocrinology and Metabolism|August 25, 2015
Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementationJoseph R Tucci, Henry G Bone, Guoqin Su, et al.
Clinical Therapeutics|May 24, 2008
Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluationE Michael Lewiecki, Ann M Babbitt, Veronica K Piziak, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Alendronate increases bone mass and reduces bone markers in postmenopausal African-American womenNorman H Bell, John P Bilezikian, Henry G Bone, et al.
Pageof 6